Trial Profile
Randomized, Double-blind, Placebo-controlled, Parallel-group Pilot Study to Assess Efficacy, Safety and Pharmacokinetics of 2 Schedules of Reparixin in the Prevention of Delayed Graft Function After Kidney Transplant in High Risk Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Reparixin (Primary)
- Indications Delayed graft function
- Focus Therapeutic Use
- Sponsors Dompe Spa
- 20 Jun 2014 New trial record
- 26 Nov 2008
- 21 Jun 2007